Renal Insufficiency  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00102947: Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Terminated
4
72
US
daptomycin (up to 14 days)
Cubist Pharmaceuticals LLC
Soft Tissue Infections
11/06
11/06
RENSE, NCT01104662: Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Terminated
4
92
US
Vancomycin, Daptomycin, Cubicin, Semi-Synthetic Penicillin, SSP, nafcillin, oxacillin, cloxacillin
Cubist Pharmaceuticals LLC
Complicated Skin and Skin Structure Infections, S. Aureus Bacteremia, Renal Impairment
06/12
06/12

Download Options